Literature DB >> 17409120

Prophylactic mastectomy: ethical issues.

Francois Eisinger1.   

Abstract

INTRODUCTION: Why in particular should prophylactic mastectomy be seen more as an ethical concern than as a strictly medical question? In this article, four main explanations will be discussed. MAIN POINTS: First, a risky condition is not a disease and prevention does not improve well-being. The benefits are only statistical and make sense at the population level. Secondly, the cause of the risk is a genetic factor and some might argue about genetic 'exceptionalism'. Thirdly, there is no organ as, connected to femininity, sensuality, sexuality, adulthood and motherhood as the breast. Lastly, making tough and complex choices requires assistance from ethics. AREAS OF AGREEMENT: Among ethical principles, western countries often rely on autonomy. The physician has to deliver all the relevant information; based on this 'knowledge' and using their own values, patients will take a decision. AREA OF CONTROVERSY: In 1998 in France, national recommendations set a list of criteria to fulfil, reducing autonomy. EMERGING AREAS FOR DEVELOPING RESEARCH: It might be expected that this tough issue will be solved, thanks to the improvement of prevention and therapeutic efficacy.

Entities:  

Mesh:

Year:  2007        PMID: 17409120     DOI: 10.1093/bmb/ldm003

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  4 in total

1.  Is human enhancement also a personal matter?

Authors:  Vincent Menuz; Thierry Hurlimann; Béatrice Godard
Journal:  Sci Eng Ethics       Date:  2011-07-23       Impact factor: 3.525

2.  Angelina and Brad effect.

Authors:  Francois Eisinger
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

3.  Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile.

Authors:  K Graham; A de las Morenas; A Tripathi; C King; M Kavanah; J Mendez; M Stone; J Slama; M Miller; G Antoine; H Willers; P Sebastiani; C L Rosenberg
Journal:  Br J Cancer       Date:  2010-03-02       Impact factor: 7.640

4.  Gender and the human genome.

Authors:  Ruth Chadwick
Journal:  Mens Sana Monogr       Date:  2009-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.